Translational aspects of blood–brain barrier transport and central nervous system effects of drugs: From discovery to patients
Year: 2015
Type: review
Abstract: The development of CNS drugs is associated with high failure rates. It is postulated that too much focus has been put on BBB permeability and too little on understanding BBB transport, which is the main limiting factor in drug delivery to the brain. An integrated approach to collecting, understanding, and handling pharmacokinetic-pharmacodynamic information from early discovery stages to the clinic is therefore recommended in order to improve translation to human drug treatment.
DOI: 10.1002/cpt.76
Authors: ECM de Lange, M Hammarlund‐Udenaes
Institutions: Leiden University, Uppsala University
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2006205371
